ATE204173T1 - Verwendung von 1-beta-d-ribofuranosyl-1,2,4- triazol-3-carboxamid (ribavirin) zur herstellung eines medikaments für die behandlung von arboviren - Google Patents

Verwendung von 1-beta-d-ribofuranosyl-1,2,4- triazol-3-carboxamid (ribavirin) zur herstellung eines medikaments für die behandlung von arboviren

Info

Publication number: ATE204173T1
Authority: AT; Austria
Prior art keywords: ribofuranosyl; carboxamide; triazole; arboviruses; ribavirin
Prior art date: 1984-10-29

Application number

AT94118300T

Other languages

English (en)

Inventor

Robert Angus Smith

Humberto Fernandes

Original Assignee

Vira Tek Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-10-29

Filing date

1985-04-16

Publication date

2001-09-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24673430&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE204173(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1985-04-16 Application filed by Vira Tek Inc filed Critical Vira Tek Inc

2001-09-15 Application granted granted Critical

2001-09-15 Publication of ATE204173T1 publication Critical patent/ATE204173T1/de

Links

IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 title 2
229940079593 drug Drugs 0.000 title 1
239000003814 drug Substances 0.000 title 1
229960000329 ribavirin Drugs 0.000 title 1
HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 title 1
241000725643 Respiratory syncytial virus Species 0.000 abstract 2
241000700605 Viruses Species 0.000 abstract 2
241000712891 Arenavirus Species 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
241000713112 Orthobunyavirus Species 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
239000002831 pharmacologic agent Substances 0.000 abstract 1
241001430294 unidentified retrovirus Species 0.000 abstract 1
230000003612 virological effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/056—Triazole or tetrazole radicals

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Pulmonology (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

AT94118300T 1984-10-29 1985-04-16 Verwendung von 1-beta-d-ribofuranosyl-1,2,4- triazol-3-carboxamid (ribavirin) zur herstellung eines medikaments für die behandlung von arboviren ATE204173T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US66625284A	1984-10-29	1984-10-29

Publications (1)

Publication Number	Publication Date
ATE204173T1 true ATE204173T1 (de)	2001-09-15

Family

ID=24673430

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT94118300T ATE204173T1 (de)	1984-10-29	1985-04-16	Verwendung von 1-beta-d-ribofuranosyl-1,2,4- triazol-3-carboxamid (ribavirin) zur herstellung eines medikaments für die behandlung von arboviren

Country Status (18)

Country	Link
EP (3)	EP0383361A3 (de)
JP (1)	JPH0713019B2 (de)
KR (1)	KR860003018A (de)
AT (1)	ATE204173T1 (de)
AU (1)	AU584333B2 (de)
BE (1)	BE902199A (de)
CA (1)	CA1261265A (de)
DD (1)	DD261094A5 (de)
DE (3)	DE3588232T2 (de)
ES (1)	ES8704962A1 (de)
FR (1)	FR2572286B1 (de)
GB (1)	GB2166050B (de)
LU (1)	LU85854A1 (de)
NL (1)	NL300083I1 (de)
NZ (1)	NZ212510A (de)
PH (1)	PH22534A (de)
PT (1)	PT81387B (de)
ZA (1)	ZA858237B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1987003903A1 (en) *	1985-12-23	1987-07-02	Fred Hutchinson Cancer Research Center	Regulating retroviral replication, infection, and pathogenesis
JP2792246B2 (ja) *	1991-01-31	1998-09-03	信越半導体株式会社	単結晶棒クランプ位置決め治具及びこれを用いた単結晶棒クランプ位置決め方法
CA2357735A1 (en) *	1999-01-29	2000-08-03	Icn Pharmaceuticals, Inc.	Modulation of immune response by ribavirin
US6720000B2 (en)	2001-03-19	2004-04-13	Three Rivers Pharmaceutical, Llc	Process for producing wet ribavirin pellets
US7132453B2 (en) *	2002-03-15	2006-11-07	Vanderbilt University	Method of using prostacyclin to treat respiratory syncytial virus infections
US7538094B2 (en)	2002-09-19	2009-05-26	Three Rivers Pharmacueticals, Llc	Composition containing ribavirin and use thereof
WO2015197549A1 (en)	2014-06-23	2015-12-30	Sanovel Ilac Sanayi Ve Ticaret A.S.	A novel pharmaceutical composition of sofosbuvir and ribavirin
EP2959901A1 (de)	2014-06-23	2015-12-30	Sanovel Ilac Sanayi ve Ticaret A.S.	Pharmazeutische kombinationen aus sofosbuvir und ribavirin
EP2959891A1 (de)	2014-06-23	2015-12-30	Sanovel Ilac Sanayi ve Ticaret A.S.	Pharmazeutische zusammensetzungen aus sofosbuvir und ribavirin mit modifizierter freisetzung
JP2018076280A (ja) *	2016-10-28	2018-05-17	国立大学法人大分大学	ジカウイルス感染症治療用医薬組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4211771A (en) *	1971-06-01	1980-07-08	Robins Ronald K	Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
US3798209A (en) *	1971-06-01	1974-03-19	Icn Pharmaceuticals	1,2,4-triazole nucleosides
US3927216A (en) *	1971-06-01	1975-12-16	Icn Pharmaceuticals	1,2,4-Triazol E-3-carboxamides for inhibiting virus infections
AR205339A1 (es) *	1973-03-12	1976-04-30	Icn Pharmaceuticals	Sintesis de 1,2,4-triazolo-3-carboxamidas utiles como agentes antivirales
WO1983003383A1 (en) *	1982-03-29	1983-10-13	Liposome Co Inc	Stable plurilamellar vesicles

1985
- 1985-04-15 BE BE0/214849A patent/BE902199A/fr not_active IP Right Cessation
- 1985-04-16 AT AT94118300T patent/ATE204173T1/de active
- 1985-04-16 EP EP19900105678 patent/EP0383361A3/de not_active Withdrawn
- 1985-04-16 EP EP94118300A patent/EP0643970B1/de not_active Revoked
- 1985-04-16 DE DE3588232T patent/DE3588232T2/de not_active Expired - Lifetime
- 1985-04-16 GB GB8509689A patent/GB2166050B/en not_active Expired
- 1985-04-16 DE DE2002199005 patent/DE10299005I2/de active Active
- 1985-04-16 EP EP85302644A patent/EP0181050A3/de not_active Withdrawn
- 1985-04-16 DE DE198585302644T patent/DE181050T1/de active Pending
- 1985-04-17 LU LU85854A patent/LU85854A1/fr unknown
- 1985-04-30 AU AU41807/85A patent/AU584333B2/en not_active Expired
- 1985-05-07 CA CA000480878A patent/CA1261265A/en not_active Expired
- 1985-05-16 PH PH32282A patent/PH22534A/en unknown
- 1985-05-30 KR KR1019850003752A patent/KR860003018A/ko not_active Ceased
- 1985-05-30 FR FR858508143A patent/FR2572286B1/fr not_active Expired - Fee Related
- 1985-06-05 JP JP60122351A patent/JPH0713019B2/ja not_active Expired - Fee Related
- 1985-06-21 NZ NZ212510A patent/NZ212510A/xx unknown
- 1985-10-09 DD DD85281565A patent/DD261094A5/de active Search and Examination
- 1985-10-28 PT PT81387A patent/PT81387B/pt active IP Right Revival
- 1985-10-28 ZA ZA858237A patent/ZA858237B/xx unknown
- 1985-10-29 ES ES548303A patent/ES8704962A1/es not_active Expired
2002
- 2002-02-14 NL NL300083C patent/NL300083I1/nl unknown

Also Published As

Publication number	Publication date
DE181050T1 (de)	1986-12-18
PT81387B (pt)	1987-11-11
DE10299005I1 (de)	2002-05-08
NZ212510A (en)	1989-04-26
LU85854A1 (fr)	1985-12-16
EP0181050A3 (de)	1987-10-21
DE3588232T2 (de)	2002-06-13
ZA858237B (en)	1988-02-24
ES8704962A1 (es)	1987-04-16
ES548303A0 (es)	1987-04-16
EP0383361A2 (de)	1990-08-22
NL300083I1 (nl)	2002-05-01
EP0643970A3 (de)	1997-07-09
GB2166050A (en)	1986-04-30
EP0643970B1 (de)	2001-08-16
KR860003018A (ko)	1986-05-19
FR2572286A1 (fr)	1986-05-02
PT81387A (en)	1985-11-01
JPH0713019B2 (ja)	1995-02-15
FR2572286B1 (fr)	1990-03-23
HK1010985A1 (en)	1999-07-02
GB8509689D0 (en)	1985-05-22
EP0643970A2 (de)	1995-03-22
EP0181050A2 (de)	1986-05-14
EP0383361A3 (de)	1993-06-16
JPS61109723A (ja)	1986-05-28
DE3588232D1 (de)	2001-09-20
CA1261265A (en)	1989-09-26
BE902199A (fr)	1985-07-31
DE10299005I2 (de)	2004-07-01
AU584333B2 (en)	1989-05-25
PH22534A (en)	1988-10-17
AU4180785A (en)	1986-05-08
DD261094A5 (de)	1988-10-19
GB2166050B (en)	1989-08-16

Similar Documents

Publication	Publication Date	Title
ATE177421T1 (de)	1999-03-15	Wasserlösliches nimesulid-salz, sowie dessen verwendung zur behandlung von entzündungen
DE69024672D1 (de)	1996-02-22	Sprays zur Behandlung von Infektionen des Tractus Respiratorius
DE69200675D1 (de)	1994-12-22	Verwendung von Droloxifen bei der Behandlung von Knochenerkrankungen.
DE122005000002I1 (de)	2005-05-12	Verwendung von Venlafaxin oder eines Aryloxy-Propanaminderivates zur Herstellung eines Medikaments zur Behandlung von Inkontinenz.
DE3579113D1 (de)	1990-09-13	Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden.
DE3855525D1 (de)	1996-10-17	Verwendung eines Protein gebundenen Polysaccharid Zur Herstellung eines Arzneimittels für die Behandlung von AIDS.
ATE145136T1 (de)	1996-11-15	Verwendung von ketoconazol und ein retinoid zur behandlung der akne vulgaris
DE3588232D1 (de)	2001-09-20	Verwendung von 1-Beta-D-ribofuranosyl-1,2,4-triazol-3-carboxamid (Ribavirin) zur Herstellung eines Medikaments für die Behandlung von Arboviren
ATE390130T1 (de)	2008-04-15	Verwendung von inhibitoren des kqt1-kanals zur herstellung eines medikaments zur behandlung von krankheiten, die durch helminthen und ektoparasiten hervorgerufen werden
ATE79254T1 (de)	1992-08-15	Die verwendung von d-fenfluramin zur herstellung von arzneimitteln, zur behandlung von depressionen.
EP0224596A4 (de)	1987-09-15	Verwendung von aus Schisandrae Fructus extrahierten Dibenzocyclooctadien-Lignanen zur Herstellung eines Arzneimittels für die Behandlung von Leberschwäche.
DE3768150D1 (de)	1991-04-04	Verwendung eines 1,3-oxazolidin-2-on-derivates zur herstellung eines arzneimittels zur behandlung von ischaemie.
ATE25969T1 (de)	1987-04-15	1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
EP0757697A4 (de)	2000-05-17	Verwendung von agentien, die die interzellülare wechselwirkung inhibieren, in der behandlung von viralen infektionen des atemweges
ATE320263T1 (de)	2006-04-15	Verwendung von menschliche protein c zur herstellung eines arzneimittels zur behandlung von heparininduzierter thrombozytopenie
DE69632117D1 (de)	2004-05-13	Verwendung von 8,9-Dehydroestron zur Herstellung eines Arzneimittels zur Behandlung von durch freie Radikale verursachte Krankheiten
DE69626276D1 (de)	2003-03-27	Tetronsäurederivate zur behandlung von hiv- und anderen retroviruserkrankungen
DE3777709D1 (de)	1992-04-30	Verwendung von 3'azido-3'deoxythymidin zur herstellung eines arzneimittels zur behandlung von gardiasis.
DE50105253D1 (de)	2005-03-10	Verwendung von n-oleoylethanolamin zur behandlung der schuppenflechte (psoriasis)
DE68926222D1 (de)	1996-05-15	Verwendung von 1,2,3,4-Tetrahydroacridinen zur Behandlung von AIDS, sowie Verbindungen
DE69531298D1 (de)	2003-08-21	Behandlung von influenzavirus-infektion unter verwendung von antiviralen acylierung/palmitylierung von hemagglutinin hemmen
DE69529070D1 (de)	2003-01-16	Verwendung von 5,6-o-benzyliden-l-ascorbinsäure oder deren salze zur herstellung eines medikaments zur behandlung von hiv
TR199901998T2 (xx)	1999-11-22	9,10-sekokolesta-5,7,10(19)-triyen-1,3-diyol veya alfakasidol�n kullan�m�.
DE68914886D1 (de)	1994-06-01	Mittel zur Behandlung von Raynaud's Krankheit.
ATE98612T1 (de)	1994-01-15	Verfahren zur behandlung von einer waesserigen loesung, die insbesondere salpetersaeure und flusssaeure enthaelt.